A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

Speaking to a packed room in the Biotechnology Building last Friday, Ira Mellman, professor of cell biology and immunobiology and chair of the department of cell biology at Yale University, delved ...

Spatial biology first entered the omics scene about a decade ago. Since then, the technology has generated significant buzz both inside and outside of the lab—beyond its contributions to science. The ...